← Back to Search

Socio-Economic Support for HIV and Hepatitis C

N/A
Recruiting
Led By Smita Pakhalé, MD, MSc
Research Sponsored by Ottawa Hospital Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
16 years or older
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights
No Placebo-Only Group

Summary

This trial looks at the effects of employment on quality of life for people with HIV/AIDS. The study found that unemployed individuals report more depression, anxiety, social isolation, and low self-esteem than employed individuals. The study also found that employment among people living with HIV/AIDS is a strong indicator of improved quality of life.

Who is the study for?
This trial is for individuals over 16 years old who live in Ottawa or Toronto, smoke at least 10 cigarettes daily on average for the past year, and have used multiple substances within the last year. It aims to help those with low income at risk for HIV/AIDS and Hepatitis-C.
What is being tested?
The study tests a community-based program offering life skills training, counseling, health services access (including testing and treatment), education about HIV/AIDS/HCV, and poverty reduction interventions through education and work/volunteer opportunities.
What are the potential side effects?
Since this trial focuses on socio-economic interventions rather than medical treatments, traditional side effects are not applicable. However, participants may experience stress or anxiety related to new social interactions or lifestyle changes.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 16 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Average Recruitment Rate
Consent and Protocol Violation Rate
Costs of Poverty Reduction Intervention
+1 more
Secondary study objectives
Access to Work, Training, and Volunteer Opportunities
Self-Reported Efficacy
Self-Reported Quality of Life
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Active Control
Group I: Usual care armActive Control1 Intervention
We will provide the participants in this arm with pamphlets and knowledge about available services in the city through partner agencies. The life skills, training, and work arm will be offered to the usual care arm participants after the first six months of study enrollment.
Group II: Life skills, training, and work armActive Control1 Intervention
Participants will receive life-skills workshops, training, education resources and access to small-paid or volunteering positions.

Find a Location

Who is running the clinical trial?

Ottawa Hospital Research InstituteLead Sponsor
575 Previous Clinical Trials
3,094,820 Total Patients Enrolled
Smita Pakhalé, MD, MScPrincipal InvestigatorThe Ottawa Hospital

Media Library

Life skills, training, education and work/volunteer opportunities Clinical Trial Eligibility Overview. Trial Name: NCT03506867 — N/A
Substance Use Disorder Research Study Groups: Usual care arm, Life skills, training, and work arm
Substance Use Disorder Clinical Trial 2023: Life skills, training, education and work/volunteer opportunities Highlights & Side Effects. Trial Name: NCT03506867 — N/A
Life skills, training, education and work/volunteer opportunities 2023 Treatment Timeline for Medical Study. Trial Name: NCT03506867 — N/A
~23 spots leftby Mar 2027